RT

RTW Biotech Opportunities Ltd

Investment fund focused on transformative assets in the global life sciences sector.

RTW | IL

Overview

Corporate Details

ISIN(s):
GG00BKTRRM22
LEI:
549300Q7EXQQH6KF7Z84
Country:
United States of America
Address:
40 10TH AVE, 10014 NEW YORK

Description

RTW Biotech Opportunities Ltd is an investment fund that focuses on identifying and investing in transformative assets with high growth potential across the global life sciences sector. The company's portfolio is primarily composed of biotechnology and medical technology companies. Managed by RTW Investments, LP, a specialized life sciences investment firm, the fund leverages deep scientific expertise to support companies throughout their entire lifecycle, from early-stage private ventures to publicly traded entities. The investment strategy aims to provide capital and strategic support to advance the development of innovative therapies and technologies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-18 08:20
New investment in Yarrow Bioscience
English 17.3 KB
2025-12-12 08:20
Monthly Valuation Update and Factsheet
English 27.9 KB
2025-12-10 08:20
Transaction in Own Shares
English 10.6 KB
2025-12-04 08:45
Inclusion in FTSE 250 Index
English 13.9 KB
2025-12-02 08:10
Transaction in Own Shares
English 10.6 KB
2025-12-01 08:15
Total Voting Rights
English 10.1 KB
2025-11-27 08:15
Transaction in Own Shares
English 10.6 KB
2025-11-26 15:40
Transaction in Own Shares
English 11.0 KB
2025-11-25 13:10
Retail Investor Webinar
English 10.9 KB
2025-11-24 08:10
Transaction in Own Shares
English 10.6 KB
2025-11-21 08:10
Transaction in Own Shares
English 10.6 KB
2025-11-20 08:10
Transaction in Own Shares
English 10.6 KB
2025-11-14 08:10
Monthly Valuation Update and Factsheet
English 31.5 KB
2025-11-07 08:20
Evommune announces $150 million IPO
English 16.2 KB
2025-11-05 11:10
Holding(s) in Company
English 23.4 KB

Automate Your Workflow. Get a real-time feed of all RTW Biotech Opportunities Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RTW Biotech Opportunities Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RTW Biotech Opportunities Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

029 Group SE Logo
Global investment platform for the hospitality and lifestyle sectors.
Germany
Z29
An ETF holding spot ether to track its performance, with potential staking rewards.
United States of America
TETH
2invest AG Logo
An investment company focusing on biotech, life science, and IT sectors globally.
Germany
2INV
3i Group PLC Logo
An international investment company focused on Private Equity and Infrastructure.
United Kingdom
III
450 PLC Logo
An acquisition vehicle acquiring businesses in creative, e-commerce, and retail.
United Kingdom
450
4Aim SICAF Logo
An investment fund investing in listed or pre-listing SMEs, offering advisory.
Italy
AIM
Abacus Global Management, Inc. Logo
An alternative asset manager specializing in life insurance policy investments.
United States of America
ABL
Abc Company Logo
A business accelerator and consulting firm specializing in club deals for SMEs.
Italy
ABC
AB Effectenbeteiligungen AG Logo
Investment company acquiring equity stakes, primarily in small and mid-cap companies.
Austria
ABE
Aberforth Geared Value & Income Trust PLC Logo
A fixed-life investment trust investing in a value portfolio of smaller companies.
United Kingdom
AGVI

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.